OrganaBio Acquires Excellos Assets to Expand Nationwide Cell Therapy Testing, Development and Manufacturing Services

OrganaBio Acquires Excellos Assets to Expand Nationwide Cell Therapy Testing, Development and Manufacturing Capabilities OrganaBio, a U.S.-based manufacturer of GMP-compliant cellular products and provider of cell isolation and cryopreservation services,…

Read MoreOrganaBio Acquires Excellos Assets to Expand Nationwide Cell Therapy Testing, Development and Manufacturing Services

Rapid Medical’s TIGERTRIEVER 13 Shows Encouraging 90-Day Results in DISTALS Trial, Supporting Key Safety and Efficacy Data

Rapid Medical Reports Positive DISTALS Trial Results for TIGERTRIEVER 13 in Distal Stroke Treatment Rapid Medical, a medical technology company focused on advanced stroke treatment solutions, has announced full results…

Read MoreRapid Medical’s TIGERTRIEVER 13 Shows Encouraging 90-Day Results in DISTALS Trial, Supporting Key Safety and Efficacy Data

Reprieve Cardiovascular Publishes FASTR Pilot Trial Findings in Journal of the American College of Cardiology: Heart Failure

Reprieve Cardiovascular Reports Published FASTR Pilot Study Results Supporting Potential New Approach for Acute Heart Failure Treatment Reprieve Cardiovascular, a development-stage medical technology company focused on transforming the treatment of…

Read MoreReprieve Cardiovascular Publishes FASTR Pilot Trial Findings in Journal of the American College of Cardiology: Heart Failure